trending Market Intelligence /marketintelligence/en/news-insights/trending/pzrw01hlrfwdkvcfsz-vqa2 content esgSubNav
In This List

Immune Design director resigns

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Immune Design director resigns

Immune Design Corp. said Peter Svennilson resigned as the company's director, effective Aug. 31.

Svennilson joined the company's board in March 2013. Immune Design noted that his resignation was not due to any disagreement with the company's operations, policies or practices.

Seattle-based Immune Design is an immunotherapy company developing in vivo cancer treatments.